$0.36 - BCAB | BioAtla, Inc. Common Stock

BioAtla, Inc. Common Stock (BCAB)

BioAtla, Inc. Common Stock

XNAS:BCAB

0.36

-10.11%

Ask

$0.44 - 100.00

Bid

$0.36 - 2,890.00

Low

$0.36

High

$0.41

Open

$0.4

Prev Close

$0.4

52W High

1.43

52W Low

0.24

Volume

1772899

Avg Vol (3m)

2609075.4

Float

44913499.97

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Biotechnology

Date Listed: 12/16/2020

Primary Exchange: XNAS

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

Phone: 858-558-0708

Address: 11085 Torreyana Road

City: San Diego

State: CA

Postal Code: 92121

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.310000

P/B (TTM)

-0.677900

Round Lot

100

Composit FIGI

BBG00Y6GBT61

Share Class FIGI

BBG00Y6GBV39

Share Class Shares Outstanding

58.72M

Weighted Shares Outstanding

58.72M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion